Greenwich LifeSciences, Inc. - COM (GLSI)

Historical Holders from Q3 2020 to Q3 2025

Type / Class
Equity / COM
Symbol
GLSI on Nasdaq
Price per share
$9.95
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
1,214,197
Total reported value
$12,081,502
% of total 13F portfolios
0%
Share change
-104,975
Value change
-$993,068
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
51
Price from insider filings
$21.36
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, Greenwich LifeSciences, Inc. - COM (GLSI) has 51 institutional shareholders filing 13F forms. They hold 1,214,197 shares. .

Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 1,214,197 $12,081,502 -$993,068 995% 51
2025 Q2 1,231,674 $11,172,252 +$1,418,411 907% 51
2025 Q1 1,161,900 $11,084,861 -$205,963 954% 45
2024 Q4 1,180,752 $13,258,952 +$407,208 1,123% 41
2024 Q3 1,140,359 $16,387,570 +$1,070,451 1,437% 37
2024 Q2 1,020,904 $17,622,364 +$5,916,793 1,726% 33
2024 Q1 644,693 $12,855,318 +$2,740,211 1,994% 28
2023 Q4 535,932 $5,638,113 +$78,911 1,052% 26
2023 Q3 537,344 $4,749,933 -$815,597 884% 23
2023 Q2 628,750 $6,063,402 -$2,464,682 964.5% 23
2023 Q1 827,405 $11,410,584 +$2,160,542 1,379% 26
2022 Q4 671,281 $10,201,395 -$1,651,873 1,520% 19
2022 Q3 792,698 $7,214,000 -$2,079,093 909.5% 17
2022 Q2 1,031,908 $8,742,000 -$136,698 846.93% 25
2022 Q1 909,468 $17,860,000 +$2,451,467 1,961.09% 32
2021 Q4 759,822 $18,515,000 -$4,465,289 2,432.97% 34
2021 Q3 815,710 $31,921,000 +$221,525 3,907.06% 36
2021 Q2 810,815 $36,440,000 +$25,376,026 4,494.1% 30
2021 Q1 259,549 $8,889,000 +$5,018,995 3,411.69% 18
2020 Q4 111,645 $4,068,000 +$3,800,925 3,645.28% 14
2020 Q3 277 $1,000 +$1,000 361.01% 1